Close Menu
  • Drugs
  • Diseases
  • Medical Tests
  • Health Topics
  • Quiz Center
  • Online Treatment Plan
  • Connect with a Doctor

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Anatomy 1

STEP 1

Toothache

Oral & Dental Health

Age-Related Cataracts

Eye Health
Facebook X (Twitter)
GoodMedTodayGoodMedToday
  • About Us
  • Support Us
Facebook X (Twitter)
SUBSCRIBE
  • Drugs
  • Diseases
  • Medical Tests
  • Health Topics
  • Quiz Center
  • Online Treatment Plan
  • Connect with a Doctor
GoodMedTodayGoodMedToday
Home - E - Etodolac
E

Etodolac

Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest WhatsApp Email

Comprehensive Guide to Etodolac: Uses, Dosage, Side Effects, and More

Table of Contents

Toggle
  • What is Etodolac?
  • Overview of Etodolac
  • Indications and Uses of Etodolac
  • Dosage of Etodolac
  • How to Use Etodolac
  • Contraindications for Etodolac
  • Warnings & Precautions for Etodolac
  • Overdose and Management of Etodolac
  • Side Effects of Etodolac
  • Drug Interactions with Etodolac
  • Patient Education or Lifestyle
  • Pharmacokinetics of Etodolac
  • Pharmacodynamics of Etodolac
  • Storage of Etodolac
  • Frequently Asked Questions (FAQs)
  • Regulatory Information
  • References

What is Etodolac?

Etodolac is a non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin synthesis to alleviate pain and inflammation. This medication is widely used for arthritis and acute pain management, administered under medical supervision to minimize adverse effects.

Overview of Etodolac

Generic Name: Etodolac

Brand Name: Lodine, generics

Drug Group: Non-steroidal anti-inflammatory drug (NSAID)

Commonly Used For

  • Relieve pain and inflammation in arthritis.
  • Manage acute pain conditions.
  • Reduce swelling in musculoskeletal disorders.

Key Characteristics

Form: Oral tablets (400 mg, 500 mg), extended-release tablets (600 mg), or capsules (200 mg, 300 mg) (detailed in Dosage section).

Mechanism: Inhibits COX enzymes, decreasing prostaglandin-mediated inflammation and pain.

Approval: FDA-approved (1991 for Lodine) and EMA-approved for arthritis and pain.

A bottle of Teva Etodolac Tablets USP 400 mg, containing 100 tablets, with a warning that each patient is required to receive a Medication Guide.
Etodolac 400 mg tablets by Teva are a nonsteroidal anti-inflammatory drug (NSAID) used to relieve pain, swelling, and joint stiffness.

Indications and Uses of Etodolac

Etodolac is indicated for a range of inflammatory and pain-related conditions, leveraging its anti-inflammatory properties:

Osteoarthritis: Treats osteoarthritis symptoms (e.g., joint pain, stiffness), improving mobility, per rheumatology guidelines, supported by clinical trials.

Rheumatoid Arthritis: Manages rheumatoid arthritis, reducing joint swelling and tenderness, recommended in combination with disease-modifying agents.

Acute Pain: Relieves moderate to severe acute pain (e.g., post-surgical, dental), providing rapid analgesia, per pain management protocols.

Ankylosing Spondylitis: Used off-label to alleviate pain and stiffness in ankylosing spondylitis, enhancing spinal mobility, with rheumatology evidence.

Gouty Arthritis: Investigated off-label for acute gout attacks, reducing inflammation, supported by rheumatologic studies.

Tendinitis and Bursitis: Manages tendinitis or bursitis pain and swelling, improving function, per orthopedic research.

Menstrual Pain (Dysmenorrhea): Treats primary dysmenorrhea, reducing uterine cramping, with gynecologic data.

Post-Traumatic Pain: Explored off-label for pain after trauma (e.g., fractures), aiding recovery, supported by trauma care studies.

Chronic Back Pain: Used off-label to manage chronic low back pain, improving quality of life, with pain medicine evidence.

Juvenile Idiopathic Arthritis: Investigated off-label in children with JIA, reducing joint symptoms, with pediatric rheumatology data.

Note: This drug requires monitoring for gastrointestinal and renal risks; consult a healthcare provider for long-term use or co-morbidities.

Dosage of Etodolac

Important Note: The dosage of this NSAID must be prescribed by a healthcare provider. Dosing varies by indication, age, and tolerance, with adjustments based on clinical evaluation.

Dosage for Adults

Osteoarthritis or Rheumatoid Arthritis:

  • Immediate-release: 300–500 mg twice or thrice daily, up to 1,000 mg/day.
  • Extended-release: 400–1,200 mg once daily, adjusted for efficacy.

Acute Pain: 200–400 mg every 6–8 hours as needed, not exceeding 1,000 mg/day.

Ankylosing Spondylitis (Off-Label): 400 mg twice daily, titrated based on response.

Dosage for Elderly (≥65 years)

Initial: 200–300 mg twice daily, with a maximum of 600 mg/day due to increased risk of side effects.

Adjustment: Titrate cautiously, monitoring for renal and GI issues.

Dosage for Pregnant Women

Pregnancy Category C: Avoid unless benefits outweigh risks (e.g., severe pain). Consult an obstetrician, with fetal monitoring.

Dosage Adjustments

Renal Impairment: Reduce to 200–300 mg/day if CrCl 30–60 mL/min; avoid if CrCl <30 mL/min.

Hepatic Impairment: Mild to moderate (Child-Pugh A or B): Reduce to 200 mg/day; severe (Child-Pugh C): Avoid.

Concomitant Medications: Adjust if combined with anticoagulants (e.g., warfarin) or other NSAIDs, increasing bleeding risk.

Dehydration: Reduce dose in dehydrated states to prevent renal toxicity.

Additional Considerations

  • Take this active ingredient with food or milk to reduce GI irritation, using a full glass of water.
  • Avoid exceeding the recommended dose to prevent toxicity.

How to Use Etodolac

Administration:

Swallow tablets or capsules whole with food or milk; take extended-release tablets once daily.

Use at consistent intervals for chronic conditions, adjusting timing as needed for acute pain.

Timing: Take as prescribed, typically 2–3 times daily for immediate-release or once daily for extended-release.

Monitoring: Watch for stomach pain, swelling, or signs of bleeding (e.g., black stools).

Additional Tips:

  • Store at 20–25°C (68–77°F), protecting from moisture and light.
  • Keep out of reach of children due to overdose risk.
  • Report severe abdominal pain, rash, or signs of kidney issues immediately.

Contraindications for Etodolac

Hypersensitivity: Patients with a known allergy to Etodolac, NSAIDs, or aspirin.

Severe Renal Impairment: Contraindicated if CrCl <30 mL/min due to accumulation risk.

Severe Hepatic Impairment: Contraindicated in Child-Pugh Class C due to toxicity.

Active Gastrointestinal Bleeding: Avoid in active peptic ulcer or GI hemorrhage.

Late Pregnancy: Contraindicated in the third trimester due to fetal risks.

Warnings & Precautions for Etodolac

General Warnings

Gastrointestinal Risk: Risk of ulcers, bleeding, or perforation; use lowest effective dose.

Cardiovascular Thrombotic Events: Risk of heart attack or stroke, especially with long-term use; monitor in at-risk patients.

Renal Toxicity: Risk of renal failure, particularly in dehydration or CKD; check kidney function.

Hepatic Effects: Risk of liver injury; monitor liver enzymes regularly.

Hypertension: May exacerbate hypertension; monitor blood pressure.

Additional Warnings

Anemia: Risk of blood loss or hemolysis; check hemoglobin levels.

Skin Reactions: Risk of Stevens-Johnson syndrome or toxic epidermal necrolysis; discontinue if rash worsens.

Asthma Exacerbation: Risk in aspirin-sensitive patients; avoid in asthmatics with NSAID sensitivity.

Fluid Retention: Risk of edema; monitor weight and swelling.

Hypersensitivity Reactions: Rare anaphylaxis; discontinue if swelling occurs.

Use in Specific Populations

Pregnancy: Category C; avoid unless critical, especially in late pregnancy.

Breastfeeding: Avoid due to potential effects on infants; monitor closely.

Elderly: Higher risk of GI and renal side effects; start with lower doses.

Children: Not recommended under 18 years due to safety data gaps.

Renal/Hepatic Impairment: Adjust dose; avoid in severe cases.

Additional Precautions

  • Inform your doctor about kidney disease, liver issues, or history of ulcers before starting this medication.
  • Avoid alcohol, which increases GI bleeding risk.

Overdose and Management of Etodolac

Overdose Symptoms

  • Nausea, vomiting, or abdominal pain.
  • Severe cases: GI bleeding, renal failure, or hypotension.
  • Drowsiness, headache, or tinnitus as early signs.
  • Seizures or respiratory depression with extremely high doses.

Immediate Actions

Contact the Medical Team: Seek immediate medical help.

Supportive Care: Administer activated charcoal if ingested recently, provide IV fluids, and monitor vital signs.

Specific Treatment: No specific antidote; manage symptoms and support organ function.

Monitor: Check kidney function, liver enzymes, and bleeding parameters for 24–48 hours.

Additional Notes

  • Overdose risk is significant; store securely and limit access.
  • Report persistent symptoms (e.g., severe stomach pain, black stools) promptly.

Side Effects of Etodolac

Common Side Effects

  • Abdominal Pain (10–15%, managed with food)
  • Nausea (8–12%, reduced with antiemetics)
  • Dizziness (5–10%, relieved with rest)
  • Headache (4–8%, managed with hydration)
  • Diarrhea (3–7%, controlled with diet)

These effects may subside with dose adjustment.

Serious Side Effects

Seek immediate medical attention for:

  • Gastrointestinal: Ulcers, bleeding, or perforation.
  • Renal: Acute kidney injury or proteinuria.
  • Cardiovascular: Myocardial infarction or stroke.
  • Hepatic: Jaundice or liver failure.
  • Allergic: Rash, angioedema, or anaphylaxis.

Additional Notes

  • Regular monitoring for kidney function, liver health, and GI status is advised.
  • Report any unusual symptoms (e.g., chest pain, severe rash) immediately to a healthcare provider.

Drug Interactions with Etodolac

This active ingredient may interact with:

  • Anticoagulants: Increases bleeding risk (e.g., warfarin); monitor INR.
  • Antiplatelets: Enhances bleeding (e.g., aspirin, clopidogrel); avoid combination.
  • ACE Inhibitors/ARBs: Reduces efficacy and increases renal risk; monitor.
  • Diuretics: Decreases natriuretic effect; adjust dose.
  • Methotrexate: Increases toxicity; use cautiously.

Action: Provide your healthcare provider with a complete list of medications.

Patient Education or Lifestyle

Medication Adherence: Take this NSAID as prescribed for pain or arthritis, following the exact schedule.

Monitoring: Report stomach pain, swelling, or signs of bleeding immediately.

Lifestyle: Avoid alcohol; use heat therapy for joint pain.

Diet: Take with food or milk; avoid high-fat meals if possible.

Emergency Awareness: Know signs of GI bleeding or kidney issues; seek care if present.

Follow-Up: Schedule regular check-ups every 1–3 months to monitor kidney, liver, and GI health.

Pharmacokinetics of Etodolac

Absorption: Well-absorbed orally (peak at 1–2 hours); food reduces peak concentration but not extent.

Distribution: Volume of distribution ~0.4 L/kg; 99% protein-bound.

Metabolism: Hepatic via CYP2C9 to inactive metabolites.

Excretion: Primarily renal (72% as metabolites); fecal (16%); half-life 6–7 hours.

Half-Life: 6–7 hours, with steady-state achieved in 2–3 days.

Pharmacodynamics of Etodolac

This drug exerts its effects by:

Inhibiting COX-1 and COX-2 enzymes, reducing prostaglandin synthesis.

Alleviating pain, inflammation, and stiffness in arthritis.

Improving joint function and mobility in chronic conditions.

Exhibiting dose-dependent risks of GI irritation and renal impairment.

Storage of Etodolac

  • Temperature: Store at 20–25°C (68–77°F); protect from moisture and excessive heat.
  • Protection: Keep in original container, away from direct sunlight and humidity.
  • Safety: Store in a locked container out of reach of children and pets due to overdose potential.
  • Disposal: Dispose of unused tablets per local regulations or consult a pharmacist, using drug take-back programs.

Frequently Asked Questions (FAQs)

Q: What does Etodolac treat?

A: This medication treats arthritis and acute pain.

Q: Can this active ingredient cause stomach issues?

A: Yes, abdominal pain is common; take with food.

Q: Is Etodolac safe for children?

A: No, not recommended under 18 years.

Q: How is this drug taken?

A: Orally as tablets or capsules, as directed.

Q: How long is Etodolac treatment?

A: Varies by condition, often short-term with monitoring.

Q: Can I use Etodolac if pregnant?

A: No, avoid unless critical; consult a doctor.

Regulatory Information

This medication is approved by:

U.S. Food and Drug Administration (FDA): Approved in 1991 (Lodine) for arthritis and pain.

European Medicines Agency (EMA): Approved for osteoarthritis, rheumatoid arthritis, and pain.

Other Agencies: Approved globally for inflammatory conditions; consult local guidelines.

References

  1. U.S. Food and Drug Administration (FDA). (2023). Lodine (Etodolac) Prescribing Information.
    • Official FDA documentation detailing the drug’s approved uses, dosage, and safety.
  2. European Medicines Agency (EMA). (2023). Etodolac Summary of Product Characteristics.
    • EMA’s comprehensive information on the medication’s indications and precautions in Europe.
  3. National Institutes of Health (NIH). (2023). Etodolac: MedlinePlus Drug Information.
    • NIH resource providing detailed information on the drug’s uses, side effects, and precautions.
  4. World Health Organization (WHO). (2023). WHO Model List of Essential Medicines: Etodolac.
    • WHO’s consideration of Etodolac for pain and inflammation.
  5. Arthritis & Rheumatology. (2022). Etodolac Efficacy in Osteoarthritis.
    • Peer-reviewed article on Etodolac efficacy (note: access may require a subscription).
Disclaimer: This article provides general information about Etodolac for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified healthcare provider, such as a rheumatologist, orthopedist, or primary care physician, before using this drug or making any medical decisions. Improper use of this active ingredient can lead to serious health risks, including gastrointestinal bleeding or renal failure.

 

PV: 63
Previous ArticleEplerenone
Next Article Ergocalciferol
Andrew Parker, MD
  • Website

Dr. Andrew Parker is a board-certified internal medicine physician with over 10 years of clinical experience. He earned his medical degree from the University of California, San Francisco (UCSF), and has worked at leading hospitals including St. Mary’s Medical Center. Dr. Parker specializes in patient education and digital health communication. He now focuses on creating clear, accessible, and evidence-based medical content for the public.

Related Posts

Valproate

November 13, 2025

Lithium

November 13, 2025

Guanfacine

November 7, 2025
Related Articles
V

Valproate

Comprehensive Guide to Valproate (Valproic Acid): Uses, Dosage, Side Effects, and More What is Valproate…

Lithium

L

Guanfacine

G

Lisdexamfetamine

L

Methylphenidate

M

Amphetamine

A
Search Drugs by Name
💊 Today’s Recommended Drug

Betamethasone

B

Oxycodone

O

Granisetron

G

Palbociclib

P

Dextromethorphan

D

Panitumumab

P

Haloperidol

H

Gabapentin

G

GoodMedToday is a global health blog providing trustworthy, reader-friendly information on diseases, medications, healthy living, and medical therapies. We help you make informed health decisions with content based on reputable medical sources.

Quick Links
Diseases & Conditions

Drugs & Medications

Symptoms

Healthy Living

Medical News

About Us
Legal & Support
Privacy Policy

Terms of Service

Medical Disclaimer

Advertising Policy

Editorial Policy
© 2025 GoodMedToday. All rights reserved.
  • Home
  • Health
  • News
  • Buy Now

Type above and press Enter to search. Press Esc to cancel.